शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
QMSMEDINSEQMS MEDICAL ALLIED S LTDHighNeutral
Announced Fri, 25 Sept, 2026 · 18:49 IST

QMS board approves healthcare demerger scheme and BeamOptics acquisition

Listed-company acquisitionDemerger ratio announcedCore business divestedStrategic Transactions View source PDFExplain this filing

QMSMEDI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+3.8%Reaction day
₹199.00
prior close
₹206.47
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-1.6%+5.3% vs market

On the reaction day the stock moved 5.3 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
+0.0
15m
+0.0
30m
+0.0
Sessions after the filingfrom the prior close
StockMarketvs market
Reaction day
+3.8-1.6+5.3
Next day
+8.9-0.6+9.5
2d
+3.5-0.8+4.3
3d
-1.7-2.1+0.4
4d
-6.6-2.1-4.5
5d
-2.5-0.8-1.7
1w
-3.5-3.8+0.3
15d
-12.6-6.9-5.7
1m
-11.1-8.0-3.0
2m
———
3m
———
UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

QMS board approved a composite scheme to demerge its Healthcare Services Business (24.41 percent of turnover at Rs 37.17 crore) and HCAH's similar unit into wholly owned Saarathi Healthcare, which will seek NSE listing. QMS shareholders get 1 Saarathi share for every 1 QMS share held. Also approved 100 percent acquisition of BeamOptics Scientific (Pune based optics and diagnostics maker) via cash or share swap. Subject to NCLT and other approvals.

Likely market impact

Healthcare arm to spin off into Saarathi for separate listing; QMS to add BeamOptics. Share swap 1:1 for QMS holders. Pending approvals.